Results 231 to 240 of about 89,427 (290)

A New Food Source: Analyzing the Nutritional Value of Plant <i>Ferulago trachycarpa</i> Boiss. [PDF]

Food Sci Nutr
Elmasulu S.
europepmc   +1 more source

Long‐Term Outcomes of Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation for Systemic Sclerosis Patients with Impaired Cardiac Function

Arthritis &Rheumatology, Accepted Article.
Objective High intensity conditioning autologous hematopoietic stem cell transplantation (AHSCT) is standard of care for patients with advanced SSc. The role of reduced intensity conditioning (RIC) prior to AHSCT in this population remains unclear. We conducted this study to determine the long‐term outcomes of RIC AHSCT in SSc patients with cardiac ...
Yonatan Lean, Carrie Richardson, Anthony Esposito, Katy Bedjeti, George E. Georges   +4 more
wiley   +1 more source

Millets for little ones: child feeding practices and nutritional profile of millet-based foods in Telangana, India. [PDF]

Front Nutr
Shaji IM, Patil S, John RM, Renjith A, Kona C, Reddy M, Ramaswamy G.   +6 more
europepmc   +1 more source

Discovery and Initial Investigation of a New Low Surface Brightness Planetary Nebula Candidate at High Galactic Latitude

Astronomische Nachrichten, EarlyView.
ABSTRACT Planetary nebulae represent a late evolutionary phase of low‐ to intermediate‐mass stars. In this article, we present the serendipitous discovery of a previously unknown, faint potential Galactic planetary nebula (PN) in the constellation Camelopardalis, identified during a survey‐inspection, aiming at the detection of dwarf companions of the ...
W. E. Celnik, P. Köchling, S. Kotov, J. Kozok, Y. Galata, L. Magrini, A. Moiseev, M. Nischang, C. Reese, P. Remmel, P. Riepe, T. Zilch, K. Werner   +12 more
wiley   +1 more source

Comparison of Accuracy in the Evaluation of Nutritional Labels on Commercial Ready-to-Eat Meal Boxes Between Professional Nutritionists and Chatbots. [PDF]

Nutrients
Hsuan CF, Lee YJ, Hsu HC, Ouyang CM, Yeh WC, Tang WH.   +5 more
europepmc   +1 more source

Switching disease‐modifying therapies in patients with spinal muscular atrophy: A systematic review on effectiveness outcomes

British Journal of Clinical Pharmacology, EarlyView.
With multiple disease‐modifying therapies now available, treatment switching has become an important clinical consideration in the management of spinal muscular atrophy (SMA). While some switches are prompted by suboptimal clinical response, more commonly they are driven by treatment burden, convenience, or adverse events.
Andrej Belančić, Elvira Meni Maria Gkrinia, Patrick Eustaquio, Andrea Katrin Faour, Dinko Vitezić   +4 more
wiley   +1 more source

Nutrition Labeling Standard

JOURNAL OF THE BREWING SOCIETY OF JAPAN, 1996
openaire   +2 more sources

Age‐related differences in hydroxychloroquine‐associated adverse events: A pharmacovigilance study based on the FDA Adverse Event Reporting System

British Journal of Clinical Pharmacology, EarlyView.
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun, Jingrong Yang, Lei Wan, Xia Xu, Jing Wang   +4 more
wiley   +1 more source

Factors influencing awareness of beverage grading policies and their association with beverage consumption patterns. [PDF]

J Health Popul Nutr
Li J, Zhang J, Hu X, Sun Y, Yu J, Wang P, Tang J, Hua M, Chen K, Na L.   +9 more
europepmc   +1 more source

Efficacy and safety of empagliflozin for treating neutropenia and neutrophil dysfunction in paediatric patients with glycogen storage disease type Ib: A systematic review and meta‐analysis

British Journal of Clinical Pharmacology, EarlyView.
Aims Glycogen storage disease type Ib (GSD‐Ib) is a rare genetic disorder causing neutropenia and neutrophil dysfunction in children. G‐CSF has been the primary treatment, but emerging data support the potential of empagliflozin, an SGLT2 inhibitor, as a promising investigational option.
Elizabeth Iwasyk, Ryan Jin, Fabio Tuzzolino, Giusy Ranucci, Donatella Madonia, Alessio Provenzani   +5 more
wiley   +1 more source